Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Total Liabilities: 2010-2021

Historic Total Liabilities for Neurocrine Biosciences (NBIX) over the last 11 years, with Sep 2021 value amounting to $671.3 million.

  • Neurocrine Biosciences' Total Liabilities fell 3.87% to $671.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $671.3 million, marking a year-over-year decrease of 3.87%. This contributed to the annual value of $608.5 million for FY2020, which is 9.06% down from last year.
  • According to the latest figures from Q3 2021, Neurocrine Biosciences' Total Liabilities is $671.3 million, which was down 0.87% from $677.2 million recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Total Liabilities peaked at $698.3 million during Q3 2020, and registered a low of $42.2 million during Q1 2017.
  • Its 3-year average for Total Liabilities is $640.7 million, with a median of $661.6 million in 2020.
  • In the last 5 years, Neurocrine Biosciences' Total Liabilities surged by 946.52% in 2018 and then decreased by 9.06% in 2020.
  • Neurocrine Biosciences' Total Liabilities (Quarterly) stood at $445.5 million in 2017, then climbed by 15.03% to $512.4 million in 2018, then soared by 30.59% to $669.1 million in 2019, then dropped by 9.06% to $608.5 million in 2020, then declined by 3.87% to $671.3 million in 2021.
  • Its Total Liabilities stands at $671.3 million for Q3 2021, versus $677.2 million for Q2 2021 and $640.8 million for Q1 2021.